These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29882970)
1. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions. Wang M; Smith JS; Wei WQ Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970 [TBL] [Abstract][Full Text] [Related]
2. Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma. Zheng YQ; Huang HH; Chen SX; Xu XE; Li ZM; Li YH; Chen SZ; Luo WX; Guo Y; Liu W; Li EM; Xu LY J Proteomics; 2024 Jul; 304():105233. PubMed ID: 38925350 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma. Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058 [TBL] [Abstract][Full Text] [Related]
4. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction. Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410 [TBL] [Abstract][Full Text] [Related]
5. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
6. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288 [TBL] [Abstract][Full Text] [Related]
7. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer. Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642 [TBL] [Abstract][Full Text] [Related]
8. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma. Zhao YX; Zhao HP; Zhao MY; Yu Y; Qi X; Wang JH; Lv J World J Gastroenterol; 2024 May; 30(20):2638-2656. PubMed ID: 38855150 [TBL] [Abstract][Full Text] [Related]
9. Baba H; Kanda M; Sawaki K; Shimizu D; Umeda S; Koike M; Kodera Y; Fujii T Anticancer Res; 2019 Nov; 39(11):5943-5951. PubMed ID: 31704819 [TBL] [Abstract][Full Text] [Related]
11. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma. Gao Y; Li M; Wang B; Ma Y Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130 [TBL] [Abstract][Full Text] [Related]
13. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma. Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084 [TBL] [Abstract][Full Text] [Related]
14. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA]. Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735 [No Abstract] [Full Text] [Related]
15. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China. Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145 [TBL] [Abstract][Full Text] [Related]
16. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related]
17. Clinical and translational advances in esophageal squamous cell carcinoma. Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905 [TBL] [Abstract][Full Text] [Related]
18. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC. Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270 [TBL] [Abstract][Full Text] [Related]
19. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma. Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis. Wang X; Lai M; Wang Y; Chai R; Li N; Ou L; Zheng K; Li J; Xu G; Wang S; Dong Y; Wang S Biomed Res Int; 2022; 2022():3758731. PubMed ID: 35496042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]